ArticleCell reports. Medicine2024

Metformin synergizes with gilteritinib in treating FLT3-mutated leukemia via targeting PLK1 signaling.

Meiling Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.